BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29566269)

  • 1. Development of the Impact of Nighttime Urination (INTU) questionnaire to assess the impact of nocturia on health and functioning.
    Abrams S; Martin S; Gillard KK; Cheng L; Fein S
    Neurourol Urodyn; 2018 Jun; 37(5):1686-1692. PubMed ID: 29566269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new patient-reported outcome (PRO) measure on the Impact of Nighttime Urination (INTU) in patients with nocturia-Psychometric validation.
    Bennett JB; Gillard KK; Banderas B; Abrams S; Cheng L; Fein S
    Neurourol Urodyn; 2018 Jun; 37(5):1678-1685. PubMed ID: 29574972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the Nocturia Sleep Quality Scale: a patient-reported outcome measure of sleep impact related to nocturia.
    Romano CD; Lewis S; Barrett A; Andersson FL; Williams V; Ancoli-Israel S; Roth T
    Sleep Med; 2019 Jul; 59():101-106. PubMed ID: 31072693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
    Hareendran A; Mannix S; Skalicky A; Bayliss M; Blumenfeld A; Buse DC; Desai PR; Ortmeier BG; Sapra S
    Health Qual Life Outcomes; 2017 Nov; 15(1):224. PubMed ID: 29149901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief.
    Rydén A; Nolan S; Maher J; Meyers O; Kündig A; Bjursell M
    BMC Nephrol; 2022 Jun; 23(1):201. PubMed ID: 35641914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nocturia Impact Diary: a self-reported impact measure to complement the voiding diary.
    Holm-Larsen T; Andersson F; van der Meulen E; Yankov V; Rosen RC; Nørgaard JP
    Value Health; 2014 Sep; 17(6):696-706. PubMed ID: 25236993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal voiding frequency does not describe nocturia-related bother.
    Rose GE; Denys MA; Kumps C; Whishaw DM; Khan F; Everaert KC; Bower WF
    Neurourol Urodyn; 2019 Aug; 38(6):1648-1656. PubMed ID: 31165518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment.
    Mathias SD; Berry P; De Vries J; Askanase A; Pascoe K; Colwell HH; Chang DJ
    Health Qual Life Outcomes; 2017 Feb; 15(1):43. PubMed ID: 28245854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
    Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
    Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials.
    Stokes J; Evans CJ; Pompilus F; Shields AL; Summers KH
    Patient; 2013; 6(4):291-305. PubMed ID: 24062234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a quality-of-life measure for men with nocturia.
    Abraham L; Hareendran A; Mills IW; Martin ML; Abrams P; Drake MJ; MacDonagh RP; Noble JG
    Urology; 2004 Mar; 63(3):481-6. PubMed ID: 15028442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturia has no impact on depression severity in patients suffering from depression but correlates with sleep quality.
    Przydacz M; Skalski M; Golabek T; Sobański JA; Klasa K; Świerkosz A; Dudek D; Chłosta P
    Psychiatr Pol; 2018 Oct; 52(5):835-842. PubMed ID: 30584817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, psychometric evaluation and cognitive debriefing of the rheumatoid arthritis symptom and impact questionnaire (RASIQ).
    Becker B; Bracher M; Chauhan D; Rendas-Baum R; Lin X; Raymond K; O'Connor M; Kosinski M
    J Patient Rep Outcomes; 2021 Dec; 5(1):129. PubMed ID: 34894330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Content Validation of Patient-Reported Sleep Measures and Development of a Conceptual Model of Sleep Disturbance in Patients with Moderate-to-Severe, Uncontrolled Asthma.
    Khan AH; Kosa K; De Prado Gomez L; Whalley D; Kamat S; Clark M
    Patient Relat Outcome Meas; 2023; 14():57-71. PubMed ID: 36992797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.
    Bonner N; Abetz-Webb L; Renault L; Caballero T; Longhurst H; Maurer M; Christiansen S; Zuraw B;
    Health Qual Life Outcomes; 2015 Jul; 13():92. PubMed ID: 26129930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' Lived Experiences of Nocturia: A Qualitative Study of the Evening, the Night, and the Next Day.
    Trigg A; Andersson FL; Aldhouse NVJ; Bliwise DL; Kitchen H
    Patient; 2017 Dec; 10(6):711-718. PubMed ID: 28425062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and content validity of a hemodialysis symptom patient-reported outcome measure.
    Flythe JE; Dorough A; Narendra JH; Wingard RL; Dalrymple LS; DeWalt DA
    Qual Life Res; 2019 Jan; 28(1):253-265. PubMed ID: 30229532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the Alcohol Quality of Life Scale (AQoLS): a new patient-reported outcome measure to assess health-related quality of life in alcohol use disorder.
    Luquiens A; Whalley D; Crawford SR; Laramée P; Doward L; Price M; Hawken N; Dorey J; Owens L; Llorca PM; Falissard B; Aubin HJ
    Qual Life Res; 2015 Jun; 24(6):1471-81. PubMed ID: 25407634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.